105 Publications (Page 1 of 5)
2021
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity.Zhou, Zhuolong⋅Zhou, Zhuolong⋅⋅Zhou, Zhuolong⋅⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Yu, Tao⋅Yu, Tao⋅Yu, Tao⋅Yu, Tao⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Ao, Zheng⋅Ao, Zheng⋅Ao, Zheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Yang, Yang⋅Yang, Yang⋅Yang, Yang⋅Yang, Yang⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Haniyeh, Eyvani⋅Cox, Mary L⋅Cox, Mary L⋅Cox, Mary L⋅Cox, Mary L⋅Wang, Xiyu⋅Wang, Xiyu⋅Wang, Xiyu⋅Wang, Xiyu⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Guo, Feng⋅Guo, Feng⋅Guo, Feng⋅Guo, Feng⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅⋅⋅Lu, Xiongbin⋅Lu, Xiongbin and Lu, XiongbinNature biomedical engineering, vol. 5, (no. 11), pp. 1320-1335, November 2021.
| Journal Article
Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia.Niu, Yi⋅Lin, Ziyou⋅Wan, Arabella⋅Sun, Lei⋅Yan, Shijia⋅Liang, Heng⋅Zhan, Siyue⋅Chen, Dongshi⋅Bu, Xianzhang⋅Liu, Peiqing⋅Chen, Ceshi⋅He, Weiling⋅Lu, Xiongbin and Wan, GuohuiHepatology (Baltimore, Md.), vol. 74, (no. 3), pp. 1461-1479, September 2021.
| Journal Article
MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentationFang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Y, Fang⋅Fang, Yuanzhang⋅Wang, Lifei⋅L, Wang⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅C, Wan⋅Wan, Changlin⋅Wan, Changlin⋅Wan, Changlin⋅Wan, Changlin⋅Sun, Yifan⋅Sun, Yifan⋅Y, Sun⋅Sun, Yifan⋅Sun, Yifan⋅Jeught K, Van⋅VAn der Jeught, Kevin⋅VAn der Jeught, Kevin⋅VAn der Jeught, Kevin⋅VAn der Jeught, Kevin⋅Zhou, Zhuolong⋅Z, Zhou⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Dong, Tianhan⋅T, Dong⋅Dong, Tianhan⋅Dong, Tianhan⋅Dong, Tianhan⋅So, Ka M⋅KM, So⋅So, Ka M⋅So, Ka M⋅So, Ka M⋅Yu, Tao⋅Yu, Tao⋅Yu, Tao⋅T, Yu⋅Yu, Tao⋅Li, Yujing⋅Y, Li⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅H, Eyvani⋅Eyvani, Haniyeh⋅AB, Colter⋅Colter, Austyn B⋅Colter, Austyn B⋅Colter, Austyn B⋅Colter, Austyn B⋅Dong, Edward⋅E, Dong⋅Dong, Edward⋅Dong, Edward⋅Dong, Edward⋅Cao, Sha⋅S, Cao⋅Cao, Sha⋅Cao, Sha⋅Cao, Sha⋅Wang, Jin⋅J, Wang⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅Schneider, Bryan P⋅Schneider, Bryan P⋅BP, Schneider⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Sandusky, George E⋅Sandusky, George E⋅X, Zhang⋅Sandusky, George E⋅Sandusky, George E⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna and Zhang, XinnaJournal of Clinical Investigation, vol. 131, (no. 1), pp. 1-17, Jan 2021.
| Journal Article
RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancerSun, Lei⋅Wan, Arabella⋅Zhou, Zhuolong⋅Chen, Dongshi⋅Liang, Heng⋅Liu, Chuwei⋅Yan, Shijia⋅Niu, Yi⋅Lin, Ziyou⋅Zhan, Siyue⋅Wang, Shanfeng⋅Bu, Xianzhang⋅He, Weiling⋅Lu, Xiongbin⋅Xu, Anlong and Wan, GuohuiGut, vol. 70, (no. 9), pp. 1698-1712, Sep 2021.
| Journal Article
Targeted immunotherapy for HER2-low breast cancer with 17p loss.Li, Yujing⋅Sun, Yifan⋅Kulke, Michael⋅Hechler, Torsten⋅Van der Jeught, Kevin⋅Dong, Tianhan⋅He, Bin⋅Miller, Kathy D⋅Radovich, Milan⋅Schneider, Bryan P⋅Pahl, Andreas⋅Zhang, Xinna and Lu, XiongbinScience translational medicine, vol. 13, (no. 580), February 10, 2021.
| Journal Article
2020
Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancerXu, Jiangsheng⋅Xu, Jiangsheng⋅Liu, Yunhua⋅Liu, Yunhua⋅Li, Yujing⋅Li, Yujing⋅Wang, Hai⋅Wang, Hai⋅Stewart, Samantha⋅Stewart, Samantha⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Zhang, Yuntian⋅Zhang, Yuntian⋅Liu, Sheng⋅Liu, Sheng⋅Zhao, Gang⋅Zhao, Gang⋅Wan, Jun⋅Wan, Jun⋅Lu, Xiongbin⋅Lu, Xiongbin⋅He, Xiaoming and He, XiaomingNature nanotechnology, vol. 15, (no. 4), pp. 342, 2020-Apr.
| Journal Article
Bioinspired One Cell Culture Isolates Highly Tumorigenic and Metastatic Cancer Stem Cells Capable of Multilineage DifferentiationWang, Hai⋅Wang, Hai⋅Wang, Hai⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Jiang, Bin⋅Jiang, Bin⋅Jiang, Bin⋅Stewart, Samantha⋅Stewart, Samantha⋅Stewart, Samantha⋅Liu, Xuanyou⋅Liu, Xuanyou⋅Liu, Xuanyou⋅Liang, Yutong⋅Liang, Yutong⋅Liang, Yutong⋅Hancioglu, Baris⋅Hancioglu, Baris⋅Hancioglu, Baris⋅Webb, Amy⋅Webb, Amy⋅Webb, Amy⋅Fisher, John P⋅Fisher, John P⋅Fisher, John P.⋅Liu, Zhenguo⋅Liu, Zhenguo⋅Liu, Zhenguo⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Tkaczuk, Katherine H. R.⋅Tkaczuk, Katherine H R⋅Tkaczuk, Katherine H. R⋅He, Xiaoming⋅He, Xiaoming and He, XiaomingAdvanced Science, pp. 2000259, 2020-04-28.
| Journal Article
RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer.Sun, Lei⋅Wan, Arabella⋅Zhou, Zhuolong⋅Chen, Dongshi⋅Liang, Heng⋅Liu, Chuwei⋅Yan, Shijia⋅Niu, Yi⋅Lin, Ziyou⋅Zhan, Siyue⋅Wang, Shanfeng⋅Bu, Xianzhang⋅He, Weiling⋅Lu, Xiongbin⋅Xu, Anlong and Wan, GuohuiGut, November 20, 2020.
| Journal Article
ST2 as checkpoint target for colorectal cancer immunotherapyVan der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Sun, Yifan⋅Sun, Yifan⋅Sun, Yifan⋅Sun, Yifan⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Jiang, Hua⋅Jiang, Hua⋅Jiang, Hua⋅Jiang, Hua⋅Yu, Tao⋅Yu, Tao⋅Yu, Tao⋅Yu, Tao⋅Yang, Jinfeng⋅Yang, Jinfeng⋅Yang, Jinfeng⋅Yang, Jinfeng⋅Kamocka, Malgorzata M⋅Kamocka, Malgorzata M⋅Kamocka, Malgorzata M⋅Kamocka, Malgorzata M⋅So, Ka Man⋅So, Ka Man⋅So, Ka Man⋅So, Ka Man⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Sandusky, George E⋅Sandusky, George E⋅Sandusky, George E⋅Sandusky, George E⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Braun, Harald⋅Braun, Harald⋅Braun, Harald⋅Braun, Harald⋅Beyaert, Rudi⋅Beyaert, Rudi⋅Beyaert, Rudi⋅Beyaert, Rudi⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Paczesny, Sophie⋅Paczesny, Sophie⋅Paczesny, Sophie⋅Paczesny, Sophie⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin and Lu, XiongbinJCI insight, vol. 5, (no. 9), 2020-May-07.
| Journal Article
2019
Creating a capture zone in microfluidic flow greatly enhances the throughput and efficiency of cancer detectionSun, Mingrui⋅Sun, Mingrui⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Shamul, James G⋅Shamul, James G⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Husain, Syed⋅Husain, Syed⋅He, Xiaoming and He, XiaomingBiomaterials, vol. 197, pp. 170, March 2019.
| Journal Article
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat DietLuo, Yongde⋅Luo, Yongde⋅Luo, Yongde⋅Luo, Catherine K⋅Luo, Catherine K⋅Luo, Yongde⋅Luo, Yongde⋅Yang, Yaying⋅Yang, Yaying⋅Yang, Vincent W⋅Yang, Yaying⋅Yang, Vincent W⋅Yang, Yaying⋅Yang, Yaying⋅Liu, Muyun⋅Liu, Muyun⋅Liu, Yan⋅Liu, Muyun⋅Liu, Muyun⋅Liu, Muyun⋅Liu, Yan⋅Wang, Guoqiang⋅Wang, Dan⋅Wang, Dan⋅Wang, Feng⋅Wang, Xiaojie⋅Wang, Dan⋅Wang, Xiaojie⋅Wang, Dan⋅Wang, Dan⋅Wang, Feng⋅Wang, Guoqiang⋅Wang, Feng⋅Wang, Feng⋅Wang, Feng⋅Bi, Yawei⋅Bi, Yawei⋅Bi, Yawei⋅Bi, Yawei⋅Bi, Yawei⋅Ji, Juntao⋅Ji, Juntao⋅Ji, Baoan⋅Ji, Juntao⋅Ji, Baoan⋅Ji, Juntao⋅Ji, Juntao⋅Li, Xiaokun⋅Li, Zhaoshen⋅Li, Ellen⋅Li, Suyun⋅Li, Xiaokun⋅Li, Suyun⋅Li, Ellen⋅Li, Zhaoshen⋅Li, Suyun⋅Li, Suyun⋅Li, Suyun⋅Liu, Yan⋅Liu, Yan⋅Liu, Yan⋅Chen, Rong⋅Chen, Rong⋅Chen, Rong⋅Chen, Rong⋅Chen, Rong⋅Huang, Haojie⋅Huang, Haojie⋅Huang, Haojie⋅Huang, Haojie⋅Huang, Haojie⋅Wang, Xiaojie⋅Wang, Xiaojie⋅Wang, Xiaojie⋅Swidnicka-Siergiejko, Agnieszka K⋅Swidnicka-Siergiejko, Agnieszka K⋅Swidnicka-Siergiejko, Agnieszka K⋅Swidnicka-Siergiejko, Agnieszka K⋅Swidnicka-Siergiejko, Agnieszka K⋅Janowitz, Tobias⋅Janowitz, Tobias⋅Janowitz, Tobias⋅Janowitz, Tobias⋅Janowitz, Tobias⋅Beyaz, Semir⋅Beyaz, Semir⋅Beyaz, Semir⋅Beyaz, Semir⋅Beyaz, Semir⋅Wang, Guoqiang⋅Wang, Guoqiang⋅Wang, Guoqiang⋅Xu, Sulan⋅Xu, Sulan⋅Xu, Sulan⋅Xu, Sulan⋅Xu, Sulan⋅Bialkowska, Agnieszka B⋅Bialkowska, Agnieszka B⋅Bialkowska, Agnieszka B⋅Bialkowska, Agnieszka B⋅Bialkowska, Agnieszka B⋅Luo, Catherine K⋅Luo, Catherine K⋅Luo, Catherine K⋅Pin, Christoph L⋅Pin, Christoph L⋅Pin, Christoph L⋅Pin, Christoph L⋅Pin, Christoph L⋅Liang, Guang⋅Liang, Guang⋅Liang, Guang⋅Liang, Guang⋅Liang, Guang⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Weiqin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Weiqin⋅Wu, Maoxin⋅Wu, Maoxin⋅Wu, Maoxin⋅Wu, Maoxin⋅Wu, Maoxin⋅Shroyer, Kenneth R⋅Shroyer, Kenneth R⋅Shroyer, Kenneth R⋅Shroyer, Kenneth R⋅Shroyer, Kenneth R⋅Wolff, Robert A⋅Wolff, Robert A⋅Wolff, Robert A⋅Wolff, Robert A⋅Wolff, Robert A⋅Plunkett, William⋅Plunkett, William⋅Plunkett, William⋅Plunkett, William⋅Plunkett, William⋅Ji, Baoan⋅Ji, Baoan⋅Ji, Baoan⋅Li, Zhaoshen⋅Li, Zhaoshen⋅Li, Zhaoshen⋅Li, Ellen⋅Li, Ellen⋅Li, Ellen⋅Li, Xiaokun⋅Li, Xiaokun⋅Li, Xiaokun⋅Yang, Vincent W⋅Yang, Vincent W⋅Yang, Vincent W⋅Logsdon, Craig D⋅Logsdon, Craig D⋅Logsdon, Craig D⋅Logsdon, Craig D⋅Logsdon, Craig D⋅Abbruzzese, James L⋅Abbruzzese, James L⋅Abbruzzese, James L⋅Abbruzzese, James L⋅Abbruzzese, James L⋅Lu, Weiqin⋅Lu, Weiqin and Lu, WeiqinGastroenterology, vol. 157, (no. 5), pp. 1428.e11, November 2019.
| Journal Article
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancersHancock, Bradley A⋅Hancock, Bradley A⋅Hancock, Bradley A⋅Hancock, Bradley A⋅Hancock, Bradley A⋅Hancock, Bradley A⋅Chen, Yu-Hsiang⋅Chen, Yu-Hsiang⋅Chen, Yu-Hsiang⋅Chen, Yu-Hsiang⋅Chen, Yu-Hsiang⋅Chen, Yu-Hsiang⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Ahmad, Mufti N⋅Ahmad, Mufti N⋅Ahmad, Mufti N⋅Ahmad, Mufti N⋅Ahmad, Mufti N⋅Ahmad, Mufti N⋅Wedge, David C⋅Wedge, David C⋅Wedge, David C⋅Wedge, David C⋅Wedge, David C⋅Wedge, David C⋅Brinza, Dumitru⋅Brinza, Dumitru⋅Brinza, Dumitru⋅Brinza, Dumitru⋅Brinza, Dumitru⋅Brinza, Dumitru⋅Scafe, Charles⋅Scafe, Charles⋅Scafe, Charles⋅Scafe, Charles⋅Scafe, Charles⋅Scafe, Charles⋅Veitch, James⋅Veitch, James⋅Veitch, James⋅Veitch, James⋅Veitch, James⋅Veitch, James⋅Gottimukkala, Rajesh⋅Gottimukkala, Rajesh⋅Gottimukkala, Rajesh⋅Gottimukkala, Rajesh⋅Gottimukkala, Rajesh⋅Gottimukkala, Rajesh⋅Short, Walt⋅Short, Walt⋅Short, Walt⋅Short, Walt⋅Short, Walt⋅Short, Walt⋅Atale, Rutuja V⋅Atale, Rutuja V⋅Atale, Rutuja V⋅Atale, Rutuja V⋅Atale, Rutuja V⋅Atale, Rutuja V⋅Ivan, Mircea⋅Ivan, Mircea⋅Ivan, Mircea⋅Ivan, Mircea⋅Ivan, Mircea⋅Ivan, Mircea⋅Badve, Sunil S⋅Badve, Sunil S⋅Badve, Sunil S⋅Badve, Sunil S⋅Badve, Sunil S⋅Badve, Sunil S⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan and Radovich, MilanBreast cancer research : BCR, vol. 21, (no. 1), pp. 87, 2019-08-05.
| Journal Article
Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancerXu, Jiangsheng⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Wang, Hai⋅Wang, Hai⋅Wang, Hai⋅Stewart, Samantha⋅Stewart, Samantha⋅Stewart, Samantha⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Zhang, Yuntian⋅Zhang, Yuntian⋅Zhang, Yuntian⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Zhao, Gang⋅Zhao, Gang⋅Zhao, Gang⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅He, Xiaoming⋅He, Xiaoming and He, XiaomingNature nanotechnology, vol. 14, (no. 5), pp. 496, 2019-Mar-05.
| Journal Article
2018
Author Correction: Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinationsYaglom, Julia A.⋅Yaglom, Julia A.⋅Yaglom, Julia A⋅Wang, Yongmei⋅Wang, Yongmei⋅Wang, Yongmei⋅Li, Amy⋅Li, Amy⋅Li, Amy⋅Li, Zhenghu⋅Li, Zhenghu⋅Li, Zhenghu⋅Monti, Stephano⋅Monti, Stephano⋅Monti, Stephano⋅Alexandrov, Ilya⋅Alexandrov, Ilya⋅Alexandrov, Ilya⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Sherman, Michael Y.⋅Sherman, Michael Y and Sherman, Michael Y.Scientific reports, vol. 8, (no. 1), pp. 1, 2018-May-02.
| Journal Article
Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinationsYaglom, Julia A.⋅Yaglom, Julia A⋅Yaglom, Julia A⋅Yaglom, Julia A.⋅Yaglom, Julia A⋅Wang, Yongmei⋅Wang, Yongmei⋅Wang, Yongmei⋅Wang, Yongmei⋅Wang, Yongmei⋅Li, Amy⋅Li, Amy⋅Li, Amy⋅Li, Amy⋅Li, Amy⋅Li, Zhenghu⋅Li, Zhenghu⋅Li, Zhenghu⋅Li, Zhenghu⋅Li, Zhenghu⋅Monti, Stephano⋅Monti, Stephano⋅Monti, Stephano⋅Monti, Stephano⋅Monti, Stephano⋅Alexandrov, Ilya⋅Alexandrov, Ilya⋅Alexandrov, Ilya⋅Alexandrov, Ilya⋅Alexandrov, Ilya⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Sherman, Michael Y⋅Sherman, Michael Y⋅Sherman, Michael Y.⋅Sherman, Michael Y. and Sherman, Michael YScientific reports, vol. 8, (no. 1), pp. 12, 2018-02-14.
| Journal Article
Enhanced cancer therapy with cold-controlled drug release and photothermal warming enabled by one nanoplatformWang, Hai⋅Wang, Hai⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Liang, Yutong⋅Liang, Yutong⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Zhao, Gang⋅Zhao, Gang⋅Tkaczuk, Katherine H.R⋅Tkaczuk, Katherine H R⋅Lu, Xiongbin⋅Lu, Xiongbin⋅He, Xiaoming and He, XiaomingBiomaterials, vol. 180, pp. 278, October 2018.
| Journal Article
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase IILi, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Deng, Yibin⋅Deng, Yibin⋅Deng, Yibin⋅Deng, Yibin⋅Deng, Yibin⋅Deng, Yibin⋅Deng, Yibin⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Huang, Kun⋅Huang, Kun⋅Huang, Kun⋅Huang, Kun⋅Huang, Kun⋅Huang, Kun⋅Huang, Kun⋅He, Bin⋅He, Bin⋅He, Bin⋅He, Bin⋅He, Bin⋅He, Bin⋅He, Bin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin and Lu, XiongbinNature communications, vol. 9, (no. 1), pp. 15, 2018-10-22.
| Journal Article
N6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug developmentNiu, Yi⋅Wan, Arabella⋅Lin, Ziyou⋅Lu, Xiongbin and Wan, GuohuiActa Pharmaceutica Sinica B, vol. 8, (no. 6), pp. 843, 2018-10-00.
| Journal Article
Overcoming Ovarian Cancer Drug Resistance with a Cold Responsive NanomaterialWang, Hai⋅Wang, Hai⋅Wang, Hai⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Zhao, Gang⋅Zhao, Gang⋅Zhao, Gang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Jewell, Christopher M⋅Jewell, Christopher M⋅Jewell, Christopher M.⋅Fisher, John P⋅Fisher, John P⋅Fisher, John P.⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅He, Xiaoming⋅He, Xiaoming and He, XiaomingACS Central Science, vol. 4, (no. 5), pp. 581, 20180523.
| Journal Article
Regulation of protein metabolism in cancerHan, Cecil⋅Lu, Xiongbin and Nagrath, DeepakMolecular & Cellular Oncology, vol. 5, (no. 5), pp. e1285384, 9/3/2018.
| Journal Article
Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancerLiu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Van der Jeught, Kevin⋅VanderJeught, Kevin⋅Van der Jeught, Kevin⋅VanderJeught, Kevin⋅Van der Jeught, Kevin⋅VanderJeught, Kevin⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin and Lu, XiongbinThe Journal of clinical investigation, vol. 128, (no. 7), pp. 2965, 2018-07-02.
| Journal Article
Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistanceWang, Hai⋅Wang, Hai⋅Wang, Hai⋅Gao, Zan⋅Gao, Zan⋅Gao, Zan⋅Liu, Xuanyou⋅Liu, Xuanyou⋅Liu, Xuanyou⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Zhao, Shuting⋅Zhao, Shuting⋅Zhao, Shuting⋅Conroy, Daniel W⋅Conroy, Daniel W⋅Conroy, Daniel W⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Yu, Jianhua⋅Yu, Jianhua⋅Yu, Jianhua⋅Jaroniec, Christopher P⋅Jaroniec, Christopher P⋅Jaroniec, Christopher P⋅Liu, Zhenguo⋅Liu, Zhenguo⋅Liu, Zhenguo⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Li, Xiaodong⋅Li, Xiaodong⋅Li, Xiaodong⋅He, Xiaoming⋅He, Xiaoming and He, XiaomingNature communications, vol. 9, (no. 1), pp. 16, 2018-02-08.
| Journal Article
Targeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and AktKatreddy, Rajasekhara Reddy⋅Bollu, Lakshmi Reddy⋅Su, Fei⋅Xian, Na⋅Srivastava, Shivangi⋅Thomas, Rintu⋅Dai, Yubing⋅Wu, Bing⋅Xu, Yunlu⋅Rea, Michael A⋅Briggs, James M⋅Zhang, Qingyuan⋅Lu, Xiongbin⋅Huang, Gangxiong and Weihua, ZhangOncogenesis, vol. 7, (no. 1), pp. 13, 2018-Jan-23.
| Journal Article
Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancerLiu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Choi, Hyun Ho⋅Choi, Hyun Ho⋅Choi, Hyun Ho⋅Han, Cecil⋅Han, Cecil⋅Han, Cecil⋅Han, Cecil⋅Han, Cecil⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Sun, Yifan⋅Sun, Yifan⋅Sun, Yifan⋅Sun, Yifan⋅Sun, Yifan⋅Zhao, Gang⋅Zhao, Gang⋅Zhao, Gang⋅Zhao, Gang⋅Zhao, Gang⋅Zhang, Yuntian⋅Zhang, Yuntian⋅Zhang, Yuntian⋅Zhang, Yuntian⋅Zhang, Yuntian⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna and Zhang, XinnaNature communications, vol. 9, (no. 1), pp. 16, 2018-11-09.
| Journal Article
2017
Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug DiscoveryAgarwal, Pranay⋅Agarwal, Pranay⋅Wang, Hai⋅Wang, Hai⋅Sun, Mingrui⋅Sun, Mingrui⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Zhao, Shuting⋅Zhao, Shuting⋅Liu, Zhenguo⋅Liu, Zhenguo⋅Gooch, Keith J⋅Gooch, Keith J⋅Zhao, Yi⋅Zhao, Yi⋅Lu, Xiongbin⋅Lu, Xiongbin⋅He, Xiaoming and He, XiaomingACS Nano, vol. 11, (no. 7), pp. 6702, 20170725.
| Journal Article